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The first wave of cancer genome-wide association stu-
dies (GWAS) have revealed tens of independent loci
marked by common variants of unknown or likely no
functional significance that explain about 5-10% of
familial risk for the particular disease. The approach
taken to date has been conservative, and only a fraction
of information has yet to be extracted from these expen-
sive enterprises. For example, the Bonferroni procedure
for selecting candidate phase II SNPs ignores many
SNPs that happen to fail an extremely low p-value
threshold. While this procedure does guarantee control
of false positives, it seems counterintuitive to the pur-
pose of phase I, which is to generate hypotheses based
on promising candidates. Researchers have generally
combined data from the discovery phase I and other
phases and used ‘genome-wide thresholds’ based on
assuming all SNPs are independent. Linkage disequili-
brium (LD) makes it problematic to differentiate a real
signal from highly correlated proxy signals. Most pub-
lished GWAS do not examine SNP interactions due to:
(a) the high computational complexity of computing p-
values for the interaction terms, and (b) the typically
low power to detect significant interactions. It is plausi-
ble that more information should be extracted if: (i)
higher order interactions are fitted, (ii) highly selected
cases and controls are used in phase I, (iii) large replica-
tion studies are used, especially if involving existing
GWAS data, (iv) the non-independence of SNPs is
taken into account using, e.g. BEAGLE CALL or haplo-
type analyses, (v) focus is on candidate gene pathways,
and/or functional SNPs, and (vi) rarer and more SNPs,
such as is available from the Illumina 5M SNP chip, are
used. We will illustrate these ideas using data from a
GWAS of early-onset breast cancers, enriched for those
with a family history, and a GWAS using extremes sam-
ple of extremes for mammographic density. We will also
discuss the design of a large international breast cancer
GWAS using the Illumina 5M SNP chip, phase I cases
enriched for family history, population-based phase II
cases and controls, population-based family study of
candidate SNPs, and GxG analyses using ‘massively par-
allel’ super computing.
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